Article Options
Categories


Search


Advanced Search



This service is provided on D[e]nt Publishing standard Terms and Conditions. Please read our Privacy Policy. To enquire about a licence to reproduce material from endodonticsjournal.com and/or JofER, click here.
This website is published by D[e]nt Publishing Ltd, Phoenix AZ, US.
D[e]nt Publishing is part of the specialist publishing group Oral Science & Business Media Inc.

Creative Commons License


Recent Articles RSS:
Subscribe to recent articles RSS
or Subscribe to Email.

Blog RSS:
Subscribe to blog RSS
or Subscribe to Email.


 »  Home  »  Dental Implant 2  »  Effect of Biofluid Environment on the Dissolution and Flexural Strength of Calcium Phosphate Bone Cements
Effect of Biofluid Environment on the Dissolution and Flexural Strength of Calcium Phosphate Bone Cements
Discussion - References.

Bookmark and Share

Discussion.
Acidic, basic, and buffered physiological salt solutions have been used as electrolytes for evaluating the dissolution of CaP implant materials. Furthermore, in recent studies, the success of CaP implants was suggested to be dependent on their ability to resorb or degrade; thereby allowing cellular penetration. However, irrespective of the degree of crystallinity, all CaP implants will degrade or dissolve to some degree. Because the amorphous phases are expected to dissolve first, it is possible that they control the initial biological response at the ceramic surface.
Protein content of the microenvironment has also been shown to affect dissolution properties of both hydroxyapatite and CaP test samples. It has been speculated that the anionic nature of proteins causes the attraction of Ca ions. However, the influence of proteins did not have a significant effect on the dissolution quantities of calcium in comparison with media without proteins. This could be the result of the fact that calcium dissolution has been shown to be strongly dependent on the microenvironment of the surrounding media. Therefore, because the media was removed and replaced daily, it was never allowed to become supersaturated with calcium in any of the three media tested. For this reason, the solutions in which the CaP cement bars were immersed were always undersaturated with respect to Ca, subsequently causing the release of Ca from the bars into the microenvironment.

References.

Kurashina K, Kurita H, Kotani A, et al. Experimental cranioplasty   and skeletal augmentation using an alpha-tricalcium phosphate/dicalcium phosphate   dibasic/ tetracalcium phosphate monoxide cement: A preliminary short-term experiment   in rabbits. Biomaterials. 1998;19: 701-706.
Shindo ML, Costantino PD, Friedman CD, et al. Facial Skeletal augmentation   using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg. 1993;119:   185-190.
Goodman SB, Bauer TW, Carter D, et al. Norian SRS Cement augmentation in   hip fracture treatment. Clin Orthop. 1998;348:42-50.
Otsuka M, Matsuda Y, Kokubo T, et al. Drug release from a novel selfsetting   bioactive glass bone cement containing cephalexin and its physicochemical propoerties.   J Biomed Mater Res. 1995;29:33-38.
Hamanishi C, Kitamoto K, Tanaka S, et al. A self-setting TTCP-DCPD apatite   cement for release of vancomycin. J Biomed Mater Res. 1996;33:139-143.
Otsuka M, Yoneoka K, Matsuda Y, et al. Oestradiol release from self-setting   apatitic bone cement responsive to plasma-calcium level in ovariectomized rats,   and its physicochemical mechanism. J Pharm Pharmacol. 1997;49:1182-1188.
Bohner M, Lemaitre J, Van Landuyt P, et al. Gentamicin-loaded hydraulic calcium   phosphate bone cement as antibiotic delivery system. J Pharm Sci. 1997;   86:565-572.
Kveton JF, Friedman CD, Piepmeier JM, et al. Reconstruction of suboccipital   craniectomy defects with hydroxyapatite cement: A preliminary report. Laryngoscope.   1995;105:156-159.
Gresser JD, Hsu SH, Nagaoka H, et al. Analysis of a vinyl pyrrolidone/poly   (propylene fumarate) resorbable bone cement. J Biomed Mater Res. 1995;29:   1241-1247.
Chow LC. Development of selfsetting calcium phosphate cements. J Ceram   Soc Jpn. 1991;99:954-964.
B. Kasemo and J. Lausmaa. The biomaterial-tissue interface and its analogues   in surface science and technology. In: Davies JE ed. The Bone- Biomaterial   Interface. Toronto: University of Toronto Press; 1991:19-32.
Costantino PD, Friedman CD, Jones K, et al. Hydroxyapatite cement. I. Basic   chemistry and histologic properties. Arch Otolaryngol Head Neck Surg. 1991;   117:379-384.
Majeska RJ, Wuthier RE. Studies of matrix vesicles isolated from chick epiphyseal   cartilage. Association of pyrophosphatase and ATPase activities with alkaline   phosphatase. Biochem Biophys Acta. 1975;391:51-60.
Chen P, Toribara T, Warner H. Microdetermination of phosphorus. Anal   Chem. 1956;28:1756-1758.
Heinonen J, Lahti R. A new and convenient colorimetric determination of inorganic   orthophosphate and its application to the assay of inorganic pyrophosphatase.   Anal Biochem. 1981;113:313- 317.
Hergenrother P, Martin S. Determination of the kinetic parameters for phospholipase   C (Bacillus cereus) on different assay based on the quantitation of inorganic   phosphate. Analytical Biochemistry. 1997;251:45-49.
Hurson S, Lacefield W, Lucas L, et al. Effect of the crystallinity of plasma   sprayed HA coatings on dissolution. In: Transactions of the 19th Annual   Meeting of the Society for Biomaterials. Minneapolis, MN: Society for Biomaterials;   1993: 223.
Driessens FCM, van Dijk JWE, Borggreven JMPM. Biological calcium phosphates   and their role in the physiological of bone and dental tissue. I. Composition   and solubility of calcium phosphates. Calcif Tissue Res. 1978;26:127- 137.
Ducheyne P, Kim CS, and Pollack SR. The effect of phase differences on the   time-dependent variation of the zeta potential of hydroxyapatite. J Biomed   Mater Res. 1992;26:147-168.
LeGeros RZ, Orly I, Gregoire M, et al. Substrate surface dissolution and   interfacial biological mineralization. In: Davies JE, ed. The Bone-Biomaterial   Interface. Toronto: University of Toronto Press; 1991:76-88.
Whitehead RY, Lucas LC, Lacefield WR. The effect of dissolution on plasma   sprayed hydroxylapatite coatings on titanium. Clin Mater. 1993;12:31-39.
Tofe AJ, Watson BA, Cheung HS. Dense HA and microporous HA resorption. In:   Transactions of the 19th Annual Meeting of the Society for Biomaterials. Minneapolis,   MN: Society for Biomaterials; 1993:338.
Maxian SH, Liesch JB, Tiku ML, et al. Evaluation of hydroxyapatite coatings   of varying crystallinity: Cell culture and non-interference fit surgical studies.   In: Transactions of the 19th Annual Meeting of the Society for Biomaterials.   Minneapolis, MN: Society for Biomaterials; 1993:336.
Radin S, Ducheyne P, Berthold P, et al. Effect of serum proteins and osteoblasts   on the surface transformation of a calcium phosphate coating: A physicochemical   and ultrastructural study. J Biomed Mater Res. 1998;39:234-243.
Weng J, Liu Q, Wolke JGC, et al. Formation and characteristics of the apatite   layer on plasma-sprayed hydroxyapatite coatings in simulated body fluid. Biomaterials.   1997;15:1027-1035.
SA Bender, JD Bumgardner, MD Roach, et al. Effect of protein on the dissolution   of HA coatings. Biomaterials. 2000;21:299-305.
Daculsi G. Biphasic calcium phosphate concept applied to artificial bone,   implant coating and injectable bone substitute. Biomaterials. 1998;19:1473-1478.